Skin Structure, Physiology, and Pathology in Topical and Transdermal Drug Delivery
Pharmaceutics · 31.10.2024 · 16 (11) · 1403
DOI: 10.3390/pharmaceutics16111403 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 31.10.2024. Verfasst von Sofia Brito und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Advanced Materials Science and Engineering, Sungkyunkwan University, Suwon 16419, Republic of Korea. Die Arbeit wurde bisher 102-mal zitiert (Crossref) und nennt 200 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, the Ajou University Research Fund, Ministry of Education.
Abstract (Originalsprache)
Several industries are increasingly focused on enhancing the delivery of active ingredients through the skin to optimize therapeutic outcomes. By facilitating the penetration of active ingredients through the skin barrier, these enhancers can significantly improve the efficacy of various formulations, ranging from skincare products to therapeutic agents targeting systemic circulation. As the understanding of skin physiology and the mechanisms of drug absorption deepen, these industries are adopting permeation enhancers more widely, ultimately leading to better patient outcomes and expanded treatment options. However, the structure and physiological function of the skin can vary according to different factors, such as the area of the body and between individuals. These variations, along with external environmental exposures, aging and pathological conditions, introduce complexities that must be carefully considered when designing effective delivery systems. Considering the intricacies of skin structure and physiology, tailoring systems to account for regional differences, individual variability, and changes induced by environmental factors or disease is critical to optimizing therapeutic outcomes. This review discusses the features of skin structure, physiology, and pathologies, as well as the application of permeation enhancers in these contexts. Furthermore, it addresses the use of animal skin models in transdermal delivery and dermatological studies, along with the latest developments in this field.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Advanced Materials Science and Engineering, Sungkyunkwan University, Suwon 16419, Republic of Korea.
- Research Center for Advanced Materials Technology, Sungkyunkwan University, Suwon 16419, Republic of Korea.
- Department of Applied Biotechnology, Ajou University, Suwon 16499, Republic of Korea.
- Department of Biological Sciences, Ajou University, Suwon 16499, Republic of Korea.
ORCID-Profile: Bum-Ho Bin
Förderung
- by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education
- the Ajou University Research Fund
- Ministry of Education
Zitieren
APA
Brito, S., Baek, M., & Bin, B. H. (2024). Skin Structure, Physiology, and Pathology in Topical and Transdermal Drug Delivery. Pharmaceutics, 16(11), 1403. https://doi.org/10.3390/pharmaceutics16111403
Vancouver
Brito S, Baek M, Bin BH. Skin Structure, Physiology, and Pathology in Topical and Transdermal Drug Delivery. Pharmaceutics. 2024;16(11):1403. doi:10.3390/pharmaceutics16111403
BibTeX
@article{Brito2024,
author = {Brito, Sofia and Baek, Moonki and Bin, Bum-Ho},
title = {Skin Structure, Physiology, and Pathology in Topical and Transdermal Drug Delivery},
journal = {Pharmaceutics},
year = {2024},
volume = {16},
number = {11},
pages = {1403},
doi = {10.3390/pharmaceutics16111403}
}
EUVIMED